checkmate 214 trial in rcc updates
Published 5 years ago • 173 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
2:30
checkmate 214 trial update
-
1:06
dr. mckay discusses the checkmate-214 trial in rcc
-
1:32
dr. pal compares checkmate-214 and cabosun trials in rcc
-
4:23
first-line therapy options for rcc: lessons from checkmate 214 and keynote-427
-
1:37
dr. amin on rationale for checkmate-214 trial in rcc
-
1:21
dr. powles on the 42-month follow-up data from the checkmate-214 trial in rcc
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:01:19
june 29, vmr with rabih & cps team - aki
-
31:14
current treatment of advanced renal cell carcinoma, christian kollmannsberger, md
-
1:23:33
fine-tuning the wave of innovation in rcc
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
-
9:00
checkmate 214, keynote-564, and updates in treatment approaches to nccrcc
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:02
key rcc data: javelin renal 101 & checkmate 214
-
1:38
dr. mcdermott on an analysis of the checkmate-214 study in rcc
-
5:06
phase 3 checkmate - 214
-
4:13
checkmate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
5:58
checkmate 9er update confirms benefits of nivolumab–cabozantinib in rcc | cristina suárez
-
1:08
laurence albigès, md, phd, shares outcomes & updates from the checkmate 214 study in advanced rcc
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma